Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Mieres

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Heart Journal|July 28, 2007
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registryAlfredo E Rodriguez, Andrew O Maree, Juan Mieres, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 24, 2011
Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trialAlfredo E Rodriguez, Alfredo M Rodriguez-Granillo, David Antoniucci, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 8, 2016
Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registryCarlos Haiek, Carlos Fernández-Pereira, Omar Santaera, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III TrialAlfredo E Rodriguez, Liliana Grinfeld, Carlos Fernandez-Pereira, et al.
Frontiers in Cardiovascular Medicine|June 3, 2024
Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortiumAlfredo Matías Rodriguez-Granillo, Leonardo Solórzano, Gilberto Vladimir Pérez-Omaña, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 9, 2010
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trialAlfredo E Rodriguez, Cesar F Vigo, Alejandro Delacasa, et al.
Future Cardiology|November 11, 2020
Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary interventionCamila Correa-Sadouet, A Matías Rodríguez-Granillo, Camila Gallardo, et al.
Clinical Medicine Insights. Cardiology|July 10, 2019
One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers StudyAlfredo E Rodriguez, Miguel Larribau, Carlos Fernandez-Pereira, et al.
Journal of Clinical Medicine|May 14, 2025
Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) TrialAlfredo Matias Rodriguez-Granillo, Juan Mieres, Carlos Fernandez-Pereira, et al.
JAMA Cardiology|November 22, 2023
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical TrialAntonio Landi, Mirvat Alasnag, Dik Heg, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Heart Journal|July 28, 2007
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registryAlfredo E Rodriguez, Andrew O Maree, Juan Mieres, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 24, 2011
Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trialAlfredo E Rodriguez, Alfredo M Rodriguez-Granillo, David Antoniucci, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 8, 2016
Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registryCarlos Haiek, Carlos Fernández-Pereira, Omar Santaera, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III TrialAlfredo E Rodriguez, Liliana Grinfeld, Carlos Fernandez-Pereira, et al.
Frontiers in Cardiovascular Medicine|June 3, 2024
Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortiumAlfredo Matías Rodriguez-Granillo, Leonardo Solórzano, Gilberto Vladimir Pérez-Omaña, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 9, 2010
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trialAlfredo E Rodriguez, Cesar F Vigo, Alejandro Delacasa, et al.
Future Cardiology|November 11, 2020
Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary interventionCamila Correa-Sadouet, A Matías Rodríguez-Granillo, Camila Gallardo, et al.
Clinical Medicine Insights. Cardiology|July 10, 2019
One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers StudyAlfredo E Rodriguez, Miguel Larribau, Carlos Fernandez-Pereira, et al.
Journal of Clinical Medicine|May 14, 2025
Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) TrialAlfredo Matias Rodriguez-Granillo, Juan Mieres, Carlos Fernandez-Pereira, et al.
JAMA Cardiology|November 22, 2023
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical TrialAntonio Landi, Mirvat Alasnag, Dik Heg, et al.
Pageof 2